Select Page

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on September 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees options to purchase an aggregate of 11,678 shares of the company’s common stock with a per share exercise price of $60.45 and restricted stock units for an aggregate of 46,585 shares of the company’s common stock. These awards were made under GBT’s Amended and Restated 2017 Inducement Equity Plan (the Plan).